HEADER HYDROLASE 21-MAR-23 8ISR TITLE CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM CLASS A BETA-LACTAMASE, CESS-1 TITLE 2 E166Q ACYLATED BY CEFACLOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CESS-1; COMPND 5 EC: 3.5.2.6; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STENOTROPHOMONAS SP. KCTC 12332; SOURCE 3 ORGANISM_TAXID: 1793721; SOURCE 4 GENE: AXG53_04720; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS HYDROLASE, EXTENDED-SPECTRUM CLASS A BETA-LACTAMASE EXPDTA X-RAY DIFFRACTION AUTHOR B.G.JEONG,M.Y.KIM,C.S.JEONG,H.W.DO,J.H.LEE,S.S.CHA REVDAT 1 15-MAY-24 8ISR 0 JRNL AUTH B.G.JEONG,M.Y.KIM,C.S.JEONG,H.DO,J.HWANG,J.H.LEE,S.S.CHA JRNL TITL CHARACTERIZATION OF THE EXTENDED SUBSTRATE SPECTRUM OF THE JRNL TITL 2 CLASS A BETA-LACTAMASE CESS-1 FROM STENOTROPHOMONAS SP. AND JRNL TITL 3 STRUCTURE-BASED INVESTIGATION INTO ITS SUBSTRATE PREFERENCE. JRNL REF INT J ANTIMICROB AGENTS V. 63 07171 2024 JRNL REFN ISSN 1872-7913 JRNL PMID 38588869 JRNL DOI 10.1016/J.IJANTIMICAG.2024.107171 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.77 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 34507 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.7700 - 5.0300 1.00 2484 153 0.1631 0.2050 REMARK 3 2 5.0300 - 4.0000 1.00 2390 147 0.1303 0.1698 REMARK 3 3 3.9900 - 3.4900 1.00 2334 144 0.1467 0.1861 REMARK 3 4 3.4900 - 3.1700 1.00 2337 144 0.1590 0.2145 REMARK 3 5 3.1700 - 2.9500 1.00 2310 141 0.1725 0.2248 REMARK 3 6 2.9500 - 2.7700 1.00 2321 143 0.1637 0.2125 REMARK 3 7 2.7700 - 2.6300 1.00 2298 142 0.1715 0.2597 REMARK 3 8 2.6300 - 2.5200 1.00 2290 141 0.1757 0.2291 REMARK 3 9 2.5200 - 2.4200 1.00 2312 142 0.1801 0.2482 REMARK 3 10 2.4200 - 2.3400 1.00 2281 141 0.1800 0.2592 REMARK 3 11 2.3400 - 2.2600 1.00 2287 140 0.1870 0.2441 REMARK 3 12 2.2600 - 2.2000 1.00 2274 140 0.1993 0.2857 REMARK 3 13 2.2000 - 2.1400 1.00 2300 142 0.2020 0.2550 REMARK 3 14 2.1400 - 2.0900 1.00 2289 140 0.1989 0.2406 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.195 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.639 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4048 REMARK 3 ANGLE : 0.940 5490 REMARK 3 CHIRALITY : 0.053 606 REMARK 3 PLANARITY : 0.006 734 REMARK 3 DIHEDRAL : 19.478 1470 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8ISR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1300036404. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUL-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003 REMARK 200 MONOCHROMATOR : DCM SI (111) CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34518 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 8ISO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 6.5, 20% (W/V) REMARK 280 POLYETHYLENE GLYCOL (PEG) MONOMETHYL ETHER (MME) 5000, REMARK 280 MICROBATCH, TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.84000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.47000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.20500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.47000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.84000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.20500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 22 REMARK 465 SER A 23 REMARK 465 HIS A 24 REMARK 465 MET A 25 REMARK 465 PRO A 26 REMARK 465 ALA A 27 REMARK 465 ALA A 28 REMARK 465 VAL A 29 REMARK 465 GLY A 291 REMARK 465 GLY B 22 REMARK 465 SER B 23 REMARK 465 HIS B 24 REMARK 465 MET B 25 REMARK 465 PRO B 26 REMARK 465 ALA B 27 REMARK 465 ALA B 28 REMARK 465 VAL B 29 REMARK 465 GLY B 291 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB SER A 70 C14 Q6R A 301 2.15 REMARK 500 OG SER B 70 O21 Q6R B 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -135.54 49.40 REMARK 500 LYS A 115 -153.62 -131.64 REMARK 500 ASP A 143 41.85 70.76 REMARK 500 ARG A 220 -127.20 -109.98 REMARK 500 GLN A 241 -52.31 -137.49 REMARK 500 ASP A 242 6.97 -151.50 REMARK 500 CYS B 69 -134.97 44.51 REMARK 500 HIS B 105 60.23 63.28 REMARK 500 LYS B 115 -152.42 -132.33 REMARK 500 ARG B 220 -128.65 -108.13 REMARK 500 GLN B 241 -48.78 -133.14 REMARK 500 ASP B 242 7.16 -164.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1O7E RELATED DB: PDB DBREF1 8ISR A 26 291 UNP A0A126NGE0_9GAMM DBREF2 8ISR A A0A126NGE0 33 297 DBREF1 8ISR B 26 291 UNP A0A126NGE0_9GAMM DBREF2 8ISR B A0A126NGE0 33 297 SEQADV 8ISR GLY A 22 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR SER A 23 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR HIS A 24 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR MET A 25 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR GLN A 166 UNP A0A126NGE GLU 173 ENGINEERED MUTATION SEQADV 8ISR GLY B 22 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR SER B 23 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR HIS B 24 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR MET B 25 UNP A0A126NGE CLONING ARTIFACT SEQADV 8ISR GLN B 166 UNP A0A126NGE GLU 173 ENGINEERED MUTATION SEQRES 1 A 269 GLY SER HIS MET PRO ALA ALA VAL SER ASP ALA ASP PHE SEQRES 2 A 269 ALA THR LEU GLU LYS THR SER GLY GLY ARG LEU GLY VAL SEQRES 3 A 269 CYS LEU TRP HIS PRO ALA SER GLY ALA ARG TYR GLY HIS SEQRES 4 A 269 ARG MET ASP GLU ARG PHE PRO MET CYS SER THR VAL LYS SEQRES 5 A 269 PHE PRO LEU ALA ALA ALA ILE LEU HIS ARG VAL ASP ALA SEQRES 6 A 269 GLY LYS LEU SER LEU ASP GLN ARG VAL ALA VAL ARG GLN SEQRES 7 A 269 GLY ASP ILE ILE SER HIS SER PRO PHE THR GLU ARG HIS SEQRES 8 A 269 VAL GLY LYS ASP MET THR VAL ARG ASP LEU CYS ARG ALA SEQRES 9 A 269 THR LEU ILE ILE SER ASP ASN ALA ALA ALA ASN LEU LEU SEQRES 10 A 269 LEU PRO LEU ILE ASP GLY PRO ALA GLY LEU THR ALA PHE SEQRES 11 A 269 LEU GLN ALA GLN GLY ASP ARG ILE THR VAL SER ALA ARG SEQRES 12 A 269 ASN GLN PRO GLU LEU ASN HIS PHE ALA PRO GLY ASP PRO SEQRES 13 A 269 ARG ASP THR THR SER PRO ALA ALA MET ALA GLY ASN LEU SEQRES 14 A 269 GLN ARG PHE LEU LEU GLY ASP VAL LEU SER PRO ALA SER SEQRES 15 A 269 ARG GLN GLN LEU ALA ASP TRP LEU ILE ASP ASN GLN THR SEQRES 16 A 269 GLY ASP ALA ARG LEU ARG ALA GLY LEU PRO GLN GLY TRP SEQRES 17 A 269 ARG VAL GLY ASP LYS THR GLY SER ASN GLY GLN ASP THR SEQRES 18 A 269 SER ASN ASP ILE ALA ALA LEU TRP PRO LEU ALA GLY GLY SEQRES 19 A 269 ALA PRO TRP LEU LEU SER CYS TYR LEU GLN GLY SER ALA SEQRES 20 A 269 LEU ASP ASP ASP GLY ARG ASP GLY ILE LEU ARG GLN VAL SEQRES 21 A 269 GLY GLU LEU ALA GLY ALA ARG LEU GLY SEQRES 1 B 269 GLY SER HIS MET PRO ALA ALA VAL SER ASP ALA ASP PHE SEQRES 2 B 269 ALA THR LEU GLU LYS THR SER GLY GLY ARG LEU GLY VAL SEQRES 3 B 269 CYS LEU TRP HIS PRO ALA SER GLY ALA ARG TYR GLY HIS SEQRES 4 B 269 ARG MET ASP GLU ARG PHE PRO MET CYS SER THR VAL LYS SEQRES 5 B 269 PHE PRO LEU ALA ALA ALA ILE LEU HIS ARG VAL ASP ALA SEQRES 6 B 269 GLY LYS LEU SER LEU ASP GLN ARG VAL ALA VAL ARG GLN SEQRES 7 B 269 GLY ASP ILE ILE SER HIS SER PRO PHE THR GLU ARG HIS SEQRES 8 B 269 VAL GLY LYS ASP MET THR VAL ARG ASP LEU CYS ARG ALA SEQRES 9 B 269 THR LEU ILE ILE SER ASP ASN ALA ALA ALA ASN LEU LEU SEQRES 10 B 269 LEU PRO LEU ILE ASP GLY PRO ALA GLY LEU THR ALA PHE SEQRES 11 B 269 LEU GLN ALA GLN GLY ASP ARG ILE THR VAL SER ALA ARG SEQRES 12 B 269 ASN GLN PRO GLU LEU ASN HIS PHE ALA PRO GLY ASP PRO SEQRES 13 B 269 ARG ASP THR THR SER PRO ALA ALA MET ALA GLY ASN LEU SEQRES 14 B 269 GLN ARG PHE LEU LEU GLY ASP VAL LEU SER PRO ALA SER SEQRES 15 B 269 ARG GLN GLN LEU ALA ASP TRP LEU ILE ASP ASN GLN THR SEQRES 16 B 269 GLY ASP ALA ARG LEU ARG ALA GLY LEU PRO GLN GLY TRP SEQRES 17 B 269 ARG VAL GLY ASP LYS THR GLY SER ASN GLY GLN ASP THR SEQRES 18 B 269 SER ASN ASP ILE ALA ALA LEU TRP PRO LEU ALA GLY GLY SEQRES 19 B 269 ALA PRO TRP LEU LEU SER CYS TYR LEU GLN GLY SER ALA SEQRES 20 B 269 LEU ASP ASP ASP GLY ARG ASP GLY ILE LEU ARG GLN VAL SEQRES 21 B 269 GLY GLU LEU ALA GLY ALA ARG LEU GLY HET Q6R A 301 24 HET EDO A 302 4 HET EDO A 303 4 HET EDO A 304 4 HET Q6R B 301 24 HET EDO B 302 4 HETNAM Q6R (R)-2-((R)-((R)-2-AMINO-2-PHENYLACETAMIDO)(CARBOXY) HETNAM 2 Q6R METHYL)-5-CHLORO-3,6-DIHYDRO-2H-1,3-THIAZINE-4- HETNAM 3 Q6R CARBOXYLIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN Q6R CEFACLOR HETSYN EDO ETHYLENE GLYCOL FORMUL 3 Q6R 2(C15 H16 CL N3 O5 S) FORMUL 4 EDO 4(C2 H6 O2) FORMUL 9 HOH *501(H2 O) HELIX 1 AA1 ASP A 31 GLY A 42 1 12 HELIX 2 AA2 CYS A 69 THR A 71 5 3 HELIX 3 AA3 VAL A 72 ALA A 86 1 15 HELIX 4 AA4 ARG A 98 ILE A 102 5 5 HELIX 5 AA5 PHE A 108 HIS A 112 5 5 HELIX 6 AA6 VAL A 119 ILE A 129 1 11 HELIX 7 AA7 ASP A 131 LEU A 139 1 9 HELIX 8 AA8 PRO A 140 ILE A 142 5 3 HELIX 9 AA9 ASP A 143 GLY A 156 1 14 HELIX 10 AB1 PRO A 167 HIS A 171 5 5 HELIX 11 AB2 SER A 182 LEU A 195 1 14 HELIX 12 AB3 SER A 200 ASP A 213 1 14 HELIX 13 AB4 ARG A 220 GLY A 224 5 5 HELIX 14 AB5 ASP A 271 ALA A 288 1 18 HELIX 15 AB6 ARG A 289 LEU A 290 5 2 HELIX 16 AB7 SER B 30 SER B 30 5 1 HELIX 17 AB8 ASP B 31 GLY B 42 1 12 HELIX 18 AB9 CYS B 69 THR B 71 5 3 HELIX 19 AC1 VAL B 72 ALA B 86 1 15 HELIX 20 AC2 ARG B 98 ILE B 102 5 5 HELIX 21 AC3 PHE B 108 VAL B 113 5 6 HELIX 22 AC4 VAL B 119 ILE B 129 1 11 HELIX 23 AC5 ASP B 131 LEU B 139 1 9 HELIX 24 AC6 PRO B 140 ILE B 142 5 3 HELIX 25 AC7 ASP B 143 GLN B 155 1 13 HELIX 26 AC8 PRO B 167 HIS B 171 5 5 HELIX 27 AC9 SER B 182 LEU B 195 1 14 HELIX 28 AD1 SER B 200 ASP B 213 1 14 HELIX 29 AD2 ARG B 220 LEU B 225 1 6 HELIX 30 AD3 ASP B 271 ALA B 288 1 18 SHEET 1 AA1 5 ARG A 57 HIS A 60 0 SHEET 2 AA1 5 ARG A 44 TRP A 50 -1 N LEU A 49 O TYR A 58 SHEET 3 AA1 5 TRP A 259 GLN A 266 -1 O TYR A 264 N GLY A 46 SHEET 4 AA1 5 SER A 244 PRO A 252 -1 N ALA A 248 O LEU A 261 SHEET 5 AA1 5 TRP A 229 SER A 237 -1 N ARG A 230 O TRP A 251 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 AA3 2 ARG A 94 ALA A 96 0 SHEET 2 AA3 2 ASP A 116 THR A 118 -1 O MET A 117 N VAL A 95 SHEET 1 AA4 5 ARG B 57 HIS B 60 0 SHEET 2 AA4 5 ARG B 44 TRP B 50 -1 N LEU B 49 O TYR B 58 SHEET 3 AA4 5 TRP B 259 GLN B 266 -1 O TYR B 264 N GLY B 46 SHEET 4 AA4 5 SER B 244 PRO B 252 -1 N LEU B 250 O TRP B 259 SHEET 5 AA4 5 TRP B 229 SER B 237 -1 N GLY B 236 O ASN B 245 SHEET 1 AA5 2 PHE B 66 PRO B 67 0 SHEET 2 AA5 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 AA6 2 ARG B 94 ALA B 96 0 SHEET 2 AA6 2 ASP B 116 THR B 118 -1 O MET B 117 N VAL B 95 LINK OG SER A 70 C14 Q6R A 301 1555 1555 1.37 LINK OG SER B 70 C14 Q6R B 301 1555 1555 1.37 CISPEP 1 GLN A 166 PRO A 167 0 2.68 CISPEP 2 GLN B 166 PRO B 167 0 -1.58 CRYST1 61.680 70.410 130.940 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016213 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014203 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007637 0.00000